GNCA - Genocea Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Genocea Biosciences's activity chart (see below) currently has 35 price targets and 33 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 75.05 days.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 29-Apr-2022. First documented stock forecast 05-Mar-2014.

Best performing analysts who are covering GNCA - Genocea Biosciences:

Edward Tenthoff Gil Blum

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2022

$0.16

$0.16 (0.00%)

$13

4 years 6 months 3 days ago
(29-Apr-2022)

1/3 (33.33%)

$-0.12 (-42.86%)

25

Buy Since 08-Mar-2018

4 years 6 months 3 days ago
(29-Apr-2022)

0/3 (0%)

$5.4 (150.00%)

Buy Since 08-Jul-2019

$0.16

$0.16 (0.00%)

$13

4 years 6 months 3 days ago
(29-Apr-2022)

1/2 (50%)

$-0.12 (-42.86%)

25

Buy Since 15-Nov-2021

$6

$6 (0.00%)

$6

4 years 6 months 26 days ago
(06-Apr-2022)

0/2 (0%)

$4.74 (376.19%)

Buy Since 01-Mar-2019

$6

$6 (0.00%)

$7

5 years 8 months 21 days ago
(11-Feb-2021)

0/3 (0%)

$2.72 (82.93%)

Show more analysts

Please expand the browser size to see the chart

What is GNCA (Genocea Biosciences) average time for price targets to be met?

On average it took 75 days for the stock forecasts to be reached, with an average price target met ratio of 29.17%.

Which analyst most recently updated their price target on GNCA (Genocea Biosciences)?

Stephen Willey

Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?

Stephen Willey works at STIFEL and has 23 price targets and 16 ratings on GNCA

Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?

Christopher James with the highest potential upside of $136

Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?

Joseph Pantginis with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?